Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
This transaction fundamentally strengthens Scinai's CDMO platform
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Reported profit after tax declined 19% year-on-year to Rs 76 crores
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
Subscribe To Our Newsletter & Stay Updated
